The increasing incidence of chronic liver conditions associated with metabolic disorders has amplified the need for advanced therapeutic and diagnostic solutions. Non-alcoholic steatohepatitis (NASH) has emerged as a serious health concern due to its strong association with obesity, diabetes, and sedentary lifestyles.  Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market...